EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability

Dmitriy Shirokov iD, Daria Lepekhina, Valentin Manuvera iD, Margarita Bogomiakova iD, Aleksandra Strokach iD, Anastasia Kazakova, Georgij Arapidi iD, Vassili Lazarev

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262412016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Dmitriy Shirokov und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia. Hauptthemen laut MEDLINE: Melanoma, Oligopeptides, Capsid Proteins, Skin Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous melanoma is an extremely dangerous tumor disease with poor prognosis at advanced stages. Accounting for a small percentage of all skin tumors, malignant melanoma leads the mortality rate in this group of cancers. Clearly, the search for new drugs and therapeutic approaches for the treatment of cutaneous melanoma is a highly pressing issue in modern medicine. In this study, novel recombinant proteins with anti-melanoma activity, called RGD-apoptins, were produced in an E. coli expression system, and their properties were evaluated in human cell models. These chimeric proteins consist of two parts, each tumor-specific. One part of the chimeric molecule is the RGD peptide, which binds to αVβ3 integrins widely expressed on the surface of malignant melanocytes. The other part is the viral protein apoptin, known to induce programmed cell death in tumor cells but not in normal cells. This molecular design aims to enhance the specificity of potential therapeutic agent toward malignant melanoma cells while reducing cytolytic effects on healthy tissue. In a resazurin assay, RGD-apoptins decreased the viability of MeWo human melanoma cells and did not affect the viability of HaCaT human keratinocyte cell line and primary skin fibroblasts. Using an annexin V assay, we confirmed that malignant melanocytes death occurs via apoptosis. Transcriptomic analysis allowed us to dynamically evaluate the spectrum of differentially expressed genes 24 and 48 h after treating melanoma cells with recombinant RGD-apoptin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaOligopeptidesCapsid ProteinsSkin NeoplasmsRecombinant Fusion ProteinsHumansCell SurvivalCell Line, TumorApoptosisRecombinant ProteinsMelanocytes

Stichwörter der Autor:innen

MeWoRGD peptidesapoptinapoptosisdual-specificity oncolytic proteinsmelanomatherapeutic recombinant proteinstranscriptomicsαVβ3 integrins

Substanzen

arginyl-glycyl-aspartic acidOligopeptidesCapsid ProteinsRecombinant Fusion ProteinsRecombinant Proteins

Autor:innen und Institutionen

  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.
  • K.I. Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology, Moscow 109472, Russia.
  • Moscow Center for Advanced Studies, Moscow 123592, Russia.
  • Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow 117997, Russia.

ORCID-Profile: Dmitriy Shirokov, Valentin Manuvera, Margarita Bogomiakova, Aleksandra Strokach, Georgij Arapidi

Förderung

  • Russian Science Foundation

Zitieren

APA

Shirokov, D., Lepekhina, D., Manuvera, V., Bogomiakova, M., Strokach, A., Kazakova, A., Arapidi, G., & Lazarev, V. (2025). Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262412016

Vancouver

Shirokov D, Lepekhina D, Manuvera V, Bogomiakova M, Strokach A, Kazakova A, et al. Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262412016

BibTeX
@article{Shirokov2025,
  author = {Shirokov, Dmitriy and Lepekhina, Daria and Manuvera, Valentin and Bogomiakova, Margarita and Strokach, Aleksandra and Kazakova, Anastasia and Arapidi, Georgij and Lazarev, Vassili},
  title = {Recombinant RGD-Apoptins Decrease Human Melanoma Cell Viability},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262412016}
}
Kostenlos starten →